Growth Metrics

BioNTech SE (BNTX) Current Assets (2018 - 2025)

BioNTech SE's Current Assets history spans 8 years, with the latest figure at $18.8 billion for Q4 2025.

  • On a quarterly basis, Current Assets fell 6.46% to $18.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.8 billion, a 6.46% decrease, with the full-year FY2025 number at $18.2 billion, down 9.21% from a year prior.
  • Current Assets hit $18.8 billion in Q4 2025 for BioNTech SE, up from $18.5 billion in the prior quarter.
  • Over the last five years, Current Assets for BNTX hit a ceiling of $22.4 billion in Q4 2022 and a floor of $4.3 billion in Q1 2021.
  • Historically, Current Assets has averaged $18.5 billion across 5 years, with a median of $20.0 billion in 2024.
  • Biggest five-year swings in Current Assets: surged 1385.59% in 2021 and later dropped 17.21% in 2025.
  • Tracing BNTX's Current Assets over 5 years: stood at $17.2 billion in 2021, then rose by 29.72% to $22.4 billion in 2022, then decreased by 6.06% to $21.0 billion in 2023, then fell by 4.36% to $20.1 billion in 2024, then fell by 6.46% to $18.8 billion in 2025.
  • Business Quant data shows Current Assets for BNTX at $18.8 billion in Q4 2025, $18.5 billion in Q3 2025, and $18.0 billion in Q2 2025.